Gerresheimer AG
Gerresheimer AG develops and manufactures pharmaceutical primary packaging, drug delivery systems and medical devices for pharmaceutical, biotechnology and cosmetics customers. Its portfolio includes glass and polymer vials, syringes, ampoules and cartridges, autoinjectors and wearable infusors, with development and contract manufacturing services. It sold its U.S. subsidiary Centor in October 2026; the separately announced sale of global Primary Packaging Plastics remains pending.
Key facts
| Company Operating Status | Active |
|---|---|
| Ticker Symbol | 0NTI |
Land a role at Gerresheimer AG
publicOpen roles & company overview
Every live role, the locations Gerresheimer AG hires across, and the company facts — all above.
membersAlerts & tailored applications
An email the day Gerresheimer AG posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.
Get started